Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy Subjects

Barbara Finck(Coherus BioSciences (United States)), Vladimir Vexler(Coherus BioSciences (United States)), Helen Tang(University of Pennsylvania), Hillary O’Kelly(Coherus BioSciences (United States)), Francesca Civoli(Coherus BioSciences (United States)), Jennifer Hodge(Coherus BioSciences (United States))
Advances in Therapy
August 13, 2020
10.1007/s12325-020-01459-y
Cited by 18

Related Papers

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
|The Lancet|2000|1.5k
Genetic and transcriptional evolution alters cancer cell line drug response
|Nature|2018|943
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
|Arthritis & Rheumatism|2002|733
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
|Nature|2021|302